$ICPT Recent News This shocking strategy will save your

New Post Public Reply Private Reply Replies (0) Message Board

Jan 28, 2014 at 2:36 PM

$ICPT Recent News

This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 4:29 p.m. Jan. 10, 2014 - Sue Chang
Macy’s up on restructuring; Apple and Samsung to talk 4:40 p.m. Jan. 9, 2014 - Sue Chang
Stock record? Intercept Pharma up nearly 300% on drug test results 2:14 p.m. Jan. 9, 2014 - Russ Britt
Intercept Pharma, Kythera take off in IPOs 10:53 a.m. Oct. 11, 2012 - MarketWatch.com
Intercept Pharma, Kythera take off in IPOs 10:34 a.m. Oct. 11, 2012 - MarketWatch.com
In the IPO desert, Thursday brings rain 9:42 a.m. Oct. 11, 2012 - MarketWatch
Intercept Pharma 5M-share IPO prices at high end 7:06 a.m. Oct. 11, 2012 - MarketWatch.com
Stocks to watch Thursday: Ruby Tuesday, Realogy 5:44 a.m. Oct. 11, 2012 - MarketWatch

Intercept’s Fibrosis Success Gives Galectin High Hope 12:02 p.m. Today - Wall St. Cheat Sheet
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Today - Seeking Alpha
Liver Drug Race: Intercept Pharma Vs. Rivals 7:24 p.m. Jan. 26, 2014 - Seeking Alpha
Why It Could Pay Off To Look At The Big Picture Of Intercept Pharmaceuticals 3:47 p.m. Jan. 24, 2014 - Seeking Alpha
Amidst Huge Unknowns, Conatus Pharmaceuticals Worth A Closer Look 9:30 a.m. Jan. 24, 2014 - Seeking Alpha
Cramer's Lightning Round - I'm Going To Play SolarCity (1/23/14) 6:24 a.m. Jan. 24, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Buy, Buy, Buy Visa 6:00 a.m. Jan. 24, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Markets Behaving Badly 8:27 p.m. Jan. 23, 2014 - TheStreet.com
5 Drugs Stocks Nudging The Industry Higher 12:03 p.m. Jan. 22, 2014 - TheStreet.com
Strong Upward Pre-Market Activity For Intercept Pharmaceuticals (ICPT) 8:24 a.m. Jan. 22, 2014 - TheStreet.com
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013 7:00 a.m. Jan. 21, 2014 - TheStreet.com
Intercept Pharmaceuticals: 6 Different Insiders Have Sold Shares This Year 3:38 a.m. Jan. 21, 2014 - Seeking Alpha
3 Sector ETFs Surging to Start 2014 - ETF News And Commentary 10:00 a.m. Jan. 20, 2014 - Zacks.com
My Five Favorite Bio-Pharma Stocks from the J.P. Morgan Healthcare Conference 1:50 p.m. Jan. 17, 2014 - TheStreet.com
4 Biotech Stocks Making Big Moves 1:41 p.m. Jan. 17, 2014 - Wall St. Cheat Sheet
3 Biotech Stocks Where Momentum is Alive and Well 8:47 a.m. Jan. 17, 2014 - InvestorPlace.com
5 Dumbest Things on Wall Street This Week 7:00 a.m. Jan. 17, 2014 - TheStreet.com
3 Critical Factors For Intercept Bulls Now 4:02 a.m. Jan. 16, 2014 - Seeking Alpha
Athersys: Why Did Shareholders Come Knocking At The Door Once Again? 3:15 p.m. Jan. 15, 2014 - Seeking Alpha
Intercept Pharma cools off after presentation 11:04 a.m. Jan. 15, 2014 - Seeking Alpha

Intercept Pharmaceuticals, Inc. [ICPT] to Ring The NASDAQ Stock Market Closing Bell 10:00 a.m. Jan. 22, 2014 - GlobeNewswire
Harwood Feffer LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 8:00 p.m. Jan. 15, 2014 - PR Newswire - PRF
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 2:03 p.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 11:19 a.m. Jan. 13, 2014 - ACCESSWIRE
Intercept Reports Additional Details About FLINT Trial Provided by NIDDK 6:06 p.m. Jan. 12, 2014 - GlobeNewswire
Intercept to Present at the J.P. Morgan Healthcare Conference 6:31 p.m. Jan. 10, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology 7:33 a.m. Jan. 9, 2014 - GlobeNewswire
Intercept Pharmaceuticals to Provide 2013 Update on Clinical Programs for Obeticholic Acid on January 9 4:05 p.m. Jan. 2, 2014 - GlobeNewswire
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
INTERCEPT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Intercept Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 6:31 p.m. Dec. 9, 2013 - PR Newswire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results 6:05 a.m. Nov. 14, 2013 - PR Newswire
Trial Results Presentations, Public Offerings, Acquisitions and Extension Study Results - Research Report on Medtronic, Steris, Intercept, Wright, and Synageva 7:00 a.m. Oct. 23, 2013 - PR Newswire
Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders 8:02 p.m. Oct. 8, 2013 - PR Newswire
Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors 7:30 a.m. Oct. 4, 2013 - GlobeNewswire
Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA 7:00 a.m. Oct. 4, 2013 - PR Newswire
Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting 3:05 p.m. Oct. 1, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results 5:00 a.m. Aug. 13, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HK Boosts Oversight of Building Repairs Post-Blaze

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

HanAll F&B Pioneers New Path for Domestic Rice Noodles

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Fluence Energy Faces Class Action: Investors Beware

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...

Duolingo Investors Must Weigh Legal Options Now

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Purina's Docuseries Wins Big at Daytime Emmys

By Caleb Price Updated Oct 31, 2026 Category News Views 154

Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...

BAIC FOTON Eyes Africa for Bold Expansion Moves

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Main Street Merger Faces Scrutiny: What It Means for Shareholders

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

CMRE Facing Legal Heat Over Wage Allegations

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

MongoDB Faces Continued Legal Scrutiny Amid Growth Issues

MongoDB's Legal Marmite: Sticky and Spreading Well, here we are, rolling up our sleeves with MongoDB, Inc. (NasdaqGM: MDB) in the spotlight again, not for some glorious tech breakthrough but a legal brouhaha. The whip of the market is as familiar as an old leather boot to traders like us. This time, we've got Kahn Swick & Foti, LLC (KSF), spearheaded by former Attorney...